Cyclodextrin host-guest complex to facilitate sinomenine-based osteoporosis therapy

Figure 1 Scheme of the study by Xiao et al[1]. This figure is modified from the original work[1]. mTOR: Mammalian target of the rapamycin; AKT: Protein kinase B; PI3K: Phosphatidylinositol 3-kinase.

Figure 2 Illustration of the scheme to solubilise sinomenine with β-cyclodextrin and its application. SIN: Sinomenine; mTOR: Mammalian target of the rapamycin; AKT: Protein kinase B; PI3K: Phosphatidylinositol 3-kinase.